Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 7
2004 9
2005 7
2006 14
2007 16
2008 7
2009 6
2010 8
2011 8
2012 7
2013 3
2014 4
2015 3
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

88 results
Results by year
Filters applied: . Clear all
Page 1
Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy.
Choi W, Porten S, Kim S, Willis D, Plimack ER, Hoffman-Censits J, Roth B, Cheng T, Tran M, Lee IL, Melquist J, Bondaruk J, Majewski T, Zhang S, Pretzsch S, Baggerly K, Siefker-Radtke A, Czerniak B, Dinney CP, McConkey DJ. Choi W, et al. Cancer Cell. 2014 Feb 10;25(2):152-65. doi: 10.1016/j.ccr.2014.01.009. Cancer Cell. 2014. PMID: 24525232 Free PMC article. Clinical Trial.
Focus on bladder cancer.
Dinney CP, McConkey DJ, Millikan RE, Wu X, Bar-Eli M, Adam L, Kamat AM, Siefker-Radtke AO, Tuziak T, Sabichi AL, Grossman HB, Benedict WF, Czerniak B. Dinney CP, et al. Cancer Cell. 2004 Aug;6(2):111-6. doi: 10.1016/j.ccr.2004.08.002. Cancer Cell. 2004. PMID: 15324694 Free article. Review. No abstract available.
Targeted therapies in bladder cancer--an update.
Black PC, Agarwal PK, Dinney CP. Black PC, et al. Urol Oncol. 2007 Sep-Oct;25(5):433-8. doi: 10.1016/j.urolonc.2007.05.011. Urol Oncol. 2007. PMID: 17826665 Review.
Germline prognostic markers for urinary bladder cancer: obstacles and opportunities.
Chang DW, Gu J, Wu X. Chang DW, et al. Urol Oncol. 2012 Jul-Aug;30(4):524-32. doi: 10.1016/j.urolonc.2012.04.003. Urol Oncol. 2012. PMID: 22742565 Free PMC article. Review.
Novel neoadjuvant therapy paradigms for bladder cancer: results from the National Cancer Center Institute Forum.
Dinney CP, Hansel D, McConkey D, Shipley W, Hagan M, Dreicer R, Lerner S, Czerniak B, Waldman F, Groshen S, True LD, Petricoin E, Theodorescu D, Hruszkewycz A, Bajorin D. Dinney CP, et al. Urol Oncol. 2014 Nov;32(8):1108-15. doi: 10.1016/j.urolonc.2013.10.021. Epub 2014 Oct 24. Urol Oncol. 2014. PMID: 25443274 Free PMC article. Review.
The pharmacogenetic impact of inflammatory genes on bladder cancer recurrence.
Gu J, Grossman HB, Dinney CP, Wu X. Gu J, et al. Pharmacogenomics. 2005 Sep;6(6):575-84. doi: 10.2217/14622416.6.6.575. Pharmacogenomics. 2005. PMID: 16142998 Review.
Should cystectomy only be performed at high-volume hospitals by high-volume surgeons?
Black PC, Brown GA, Dinney CP. Black PC, et al. Curr Opin Urol. 2006 Sep;16(5):344-9. doi: 10.1097/01.mou.0000240307.85829.7a. Curr Opin Urol. 2006. PMID: 16905980 Review.
The impact of variant histology on the outcome of bladder cancer treated with curative intent.
Black PC, Brown GA, Dinney CP. Black PC, et al. Urol Oncol. 2009 Jan-Feb;27(1):3-7. doi: 10.1016/j.urolonc.2007.07.010. Epub 2008 Jan 14. Urol Oncol. 2009. PMID: 18367107 Review.
Bladder cancer angiogenesis and metastasis--translation from murine model to clinical trial.
Black PC, Dinney CP. Black PC, et al. Cancer Metastasis Rev. 2007 Dec;26(3-4):623-34. doi: 10.1007/s10555-007-9084-9. Cancer Metastasis Rev. 2007. PMID: 17726580 Review.
Molecular markers of urothelial cancer and their use in the monitoring of superficial urothelial cancer.
Black PC, Brown GA, Dinney CP. Black PC, et al. J Clin Oncol. 2006 Dec 10;24(35):5528-35. doi: 10.1200/JCO.2006.08.0895. J Clin Oncol. 2006. PMID: 17158538 Review.
88 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback